Abstract:333 field was opened for further investigations and the term “altered microbiota signature in T2D” was established. In this issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Salamon et al6 report on a small study where they investigated fecal microbiome in patients with T1DM, T2DM, and healthy controls. Using 16S ribosomal RNA next generation sequencing, the authors observed that patients with T2DM differed with respect to their microbiome from both T1DM subjects and healthy controls. Patients with T2DM were char acterized by a higher ratio of Firmicutes to Bac teroidetes and demonstrated reduced fecal con centrations of certain Ruminococcaceae, Lachno spiraceae, Clostridiales, Bacteroides, Anaerostipes, and Roseburia, whereas the concentrations of Ruminococcus, Enterobacteriaceae and Proteobacte ria, all rather proinflammatory bacterial strains, were increased. Proteobacteria are considered pro inflammatory and might be able to drive immune responses characterized by increased interferon γ expression.7 Concentrations of Akkermansia muciniphila, a rather well characterized commensal with mainly antidiabetic and anti inflammatory properties,8 were increased in T2DM patients in the study by Salomon et al,6 and the authors pro posed that accompanying metformin treatment might have caused this effect.9 The findings by Salamon et al6 with A muciniphila are in contrast to several other studies which have demonstrated that obesity and related metabolic dysfunction are characterized by decreased fecal concentrations of this bacterium.10 Interestingly, the microbiota composition in T1DM subjects did not differ sig nificantly from that in healthy controls.6 Some at tention regarding the presented results, however, is needed as authors could not provide data on di etary details and stool consistency, both factors substantially affecting gut microbiota composi tion. Furthermore, the number of analyzed pa tients was rather low (T1DM, n = 22; T2DM, n = 23; controls, n = 23). Despite these shortcomings, The human intestinal tract contains an enor mous number of bacteria, archaea, and virus es. Recent estimates announced that a ratio of 1.3 bacterial cells might exist for every 1 hu man cell.1 Early studies believed that genes of this microbial world mainly encode functions affecting pathways favoring digestion of com plex carbohydrates or the control of immunity, whereas recent evidence supports that the mi crobiota has major functions in the regulation of metabolic pathways in health and disease.2 It has been shown in the past years that obese human subjects exhibit a gut microbiome sig nature.3 Two major studies from the following years showed that such a microbiome signature might also exist in humans with type 2 diabe tes mellitus (T2DM).4,5 In the first metagenome wide association study, researchers from Chi na demonstrated an intestinal dysbiosis char acterized by a decrease in butyrate producing Roseburia intestinalis and Faecalibacterium prausnitzii.4 When analyzing potentially associated functions from this altered microbiota, an en richment in the membrane transport of sugars, branchedchain amino acid transport and sul phate reduction, and decreased butyrate bio synthesis could be observed. Most importantly, enriched functions also included an increase in oxidative stress pathways, offering the hypoth esis that there might be a direct link between an altered microbiota and the well known pro inflammatory state in T2DM patients. A sec ond metagenome study in patients with T2DM from Europe exhibited an increase in the abun dance of certain Lactobacillus species including Lactobacillus gasseri, Streptococcus mutans, and certain Clostridium bacteria, such as Clostridium clostridioforme, and decreases in other Clostridium species. Roseburia intestinalis and Faecalibacterium prausnitzii, both prototypic butyrate producers, were highly discriminant for T2DM.5 Although there were significant differences be tween these 2 studies, a new exciting research EDITORIAL

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

The Profile of Blood Microbiome in New-Onset Type 1 Diabetes Children

Association Between Blood Microbiome and Type 2 Diabetes Mellitus: A Nested Case‐control Study

Association of oral microbiome with type 2 diabetes risk

Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes

High-Resolution Taxonomic Characterization Reveals Novel Human Microbial Strains with Potential as Risk Factors and Probiotics for Prediabetes and Type 2 Diabetes

Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study

Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity

Enterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study

The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study

Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients

Microbiota and diabetes: an increasingly relevant association.

Periodontal Bacteria and Prediabetes Prevalence in ORIGINS: The Oral Infections, Glucose Intolerance, and Insulin Resistance Study

Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes

153-OR: Gut Microbiota, Blood Metabolome, and Incident Type 2 Diabetes in U.S. Hispanics

Gut Microbiome-Based Diagnostic Model to Predict Diabetes Mellitus

Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study

Machine Learning Reveals Time-Varying Microbial Predictors with Complex Effects on Glucose Regulation

Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice

Oral Microbiome Signatures in Diabetes Mellitus and Periodontal Disease

Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study